Andreas Karau
Andreas Karau has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Sánchez-Kopper
Centro de Investigación y de Servicios Químicos y Microbiológicos, Escuela de Química, Instituto Tecnológico de Costa Rica, Cartago P.O. Box 159-7050, Costa Rica
1 shared publication - Annabelle-Christin Herder
Institute of Technical Chemistry, Leibniz University Hannover, Callinstrasse 5, 30167 Hannover, Germany
1 shared publication - Antonina Lavrentieva
Institute of Technical Chemistry, Leibniz University Hannover, Germany
1 shared publication - Axel Seltsam
Bavarian Red Cross Blood Service Institute Nuremberg Nuremberg Germany
1 shared publication - Christian Kessler
Evonik Nutrition & Care GmbH, Essen, Germany
1 shared publication - Cécile Boudot
Evonik Nutrition & Care GmbH, Business Line Health Care, Kirschenallee, 64293 Darmstadt, Germany
1 shared publication
Latest Publications
- Open Access
Xeno-Free In Vitro Cultivation and Osteogenic Differentiation of hAD-MSCs on Resorbable 3D Printed RESOMER®
The development of alloplastic resorbable materials can revolutionize the field of implantation technology in regenerative medicine. Additional opportunities to colonize the three-dimensionally (3D) printed constructs with the patient’s own cells prior to implantation can improve the regeneration process but requires optimization of cultivation protocols. Human platelet lysate (hPL) has already proven to be a suitable replacement for fetal calf serum (FCS) in 2D and 3D cell cultures. In this study, we investigated the in vitro biocompatibility of the printed RESOMER® Filament LG D1.75 materials as well as the osteogenic differentiation of human mesenchymal stem cells (hMSCs) cultivated on 3D printed constructs under the influence of different medium supplements (FCS, human serum (HS) and hPL). Additionally, the in vitro degradation of the material was studied over six months. We demonstrated that LG D1.75 is biocompatible and has no in vitro cytotoxic effects on hMSCs. Furthermore, hMSCs grown on the constructs could be differentiated into osteoblasts, especially supported by supplementation with hPL. Over six months under physiological in vitro conditions, a distinct degradation was observed, which, however, had no influence on the biocompatibility of the material. Thus, the overall suitability of the material LG D1.75 to produce 3D printed, resorbable bone implants and the promising use of hPL in the xeno-free cultivation of human MSCs on such implants for autologous transplantation have been demonstrated.
Open AccessXeno-Free In Vitro Cultivation and Osteogenic Differentiation of hAD-MSCs on Resorbable 3D Printed RESOMER®
The development of alloplastic resorbable materials can revolutionize the field of implantation technology in regenerative medicine. Additional opportunities to colonize the three-dimensionally (3D) printed constructs with the patient’s own cells prior to implantation can improve the regeneration process but requires optimization of cultivation protocols. Human platelet lysate (hPL) has already proven to be a suitable replacement for fetal calf serum (FCS) in 2D and 3D cell cultures. In this study, we investigated the in vitro biocompatibility of the printed RESOMER® Filament LG D1.75 materials as well as the osteogenic differentiation of human mesenchymal stem cells (hMSCs) cultivated on 3D printed constructs under the influence of different medium supplements (FCS, human serum (HS) and hPL). Additionally, the in vitro degradation of the material was studied over six months. We demonstrated that LG D1.75 is biocompatible and has no in vitro cytotoxic effects on hMSCs. Furthermore, hMSCs grown on the constructs could be differentiated into osteoblasts, especially supported by supplementation with hPL. Over six months under physiological in vitro conditions, a distinct degradation was observed, which, however, had no influence on the biocompatibility of the material. Thus, the overall suitability of the material LG D1.75 to produce 3D printed, resorbable bone implants and the promising use of hPL in the xeno-free cultivation of human MSCs on such implants for autologous transplantation have been demonstrated.
- Open Access
- 22 July 2016
- Published by Springer Nature in AMB Express
- Vol. 6 (1) , 1-12
Tracking dipeptides at work-uptake and intracellular fate in CHO culture
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a result, production processes using Chinese hamster ovary cells (CHO) are in the focus of ongoing intensification studies for maximizing cell-specific and volumetric productivities. This includes the optimization of animal-derived component free (ADCF) cultivation media as part of good cell culture practice. Dipeptides are known to improve CHO culture performance. However, little or even conflicting assumptions exist about their putative import and functionality inside the cells. A set of well-known performance boosters and new dipeptide prospects was evaluated. The present study revealed that dipeptides are indeed imported in the cells, where they are decomposed to the amino acids building blocks. Subsequently, they are metabolized or, unexpectedly, secreted to the medium. Monoclonal antibody production boosting additives like l-alanine-l-glutamine (AQ) or glycyl-l-glutamine (GQ) can be assigned to fast or slow dipeptide uptake, respectively, thus pinpointing to the need to study dipeptide kinetics and to adjust their feeding individually for optimizing mAb production.
- 22 July 2016
- Published by Springer Nature in AMB Express
- Vol. 6 (1) , 1-12
Open AccessTracking dipeptides at work-uptake and intracellular fate in CHO culture
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a result, production processes using Chinese hamster ovary cells (CHO) are in the focus of ongoing intensification studies for maximizing cell-specific and volumetric productivities. This includes the optimization of animal-derived component free (ADCF) cultivation media as part of good cell culture practice. Dipeptides are known to improve CHO culture performance. However, little or even conflicting assumptions exist about their putative import and functionality inside the cells. A set of well-known performance boosters and new dipeptide prospects was evaluated. The present study revealed that dipeptides are indeed imported in the cells, where they are decomposed to the amino acids building blocks. Subsequently, they are metabolized or, unexpectedly, secreted to the medium. Monoclonal antibody production boosting additives like l-alanine-l-glutamine (AQ) or glycyl-l-glutamine (GQ) can be assigned to fast or slow dipeptide uptake, respectively, thus pinpointing to the need to study dipeptide kinetics and to adjust their feeding individually for optimizing mAb production.
- 28 March 2014
- Published by Springer Nature
- Vol. 143, 189-228
Amino Acids in Human and Animal Nutrition
Amino acids are key components of human and animal nutrition, both as part of a protein-containing diet, and as supplemented individual products. In the last 10 years there has been a marked move away from the extraction of amino acids from natural products, which has been replaced by efficient fermentation processes using nonanimal carbon sources. Today several amino acids are produced in fermentation plants with capacities of more than 100,000 tonnes to serve the requirements of animal feed and human nutrition. The main fermentative amino acids for animal nutrition are l-lysine, l-threonine, and l-tryptophan. dl-Methionine continues to be manufactured for animal feed use principally by chemical synthesis, and a pharmaceutical grade is manufactured by enzymatic resolution. Amino acids play an important role in medical nutrition, particularly in parenteral nutrition, where there are high purity requirements for infusion grade products. Amino acids are also appearing more often in dietary supplements, initially for performance athletes, but increasingly for the general population. As the understanding of the effects of the individual amino acids on the human metabolism is deepened, more specialized product mixtures are being offered to improve athletic performance and for body-building.
- 28 March 2014
- Published by Springer Nature
- Vol. 143, 189-228
Amino Acids in Human and Animal Nutrition
Amino acids are key components of human and animal nutrition, both as part of a protein-containing diet, and as supplemented individual products. In the last 10 years there has been a marked move away from the extraction of amino acids from natural products, which has been replaced by efficient fermentation processes using nonanimal carbon sources. Today several amino acids are produced in fermentation plants with capacities of more than 100,000 tonnes to serve the requirements of animal feed and human nutrition. The main fermentative amino acids for animal nutrition are l-lysine, l-threonine, and l-tryptophan. dl-Methionine continues to be manufactured for animal feed use principally by chemical synthesis, and a pharmaceutical grade is manufactured by enzymatic resolution. Amino acids play an important role in medical nutrition, particularly in parenteral nutrition, where there are high purity requirements for infusion grade products. Amino acids are also appearing more often in dietary supplements, initially for performance athletes, but increasingly for the general population. As the understanding of the effects of the individual amino acids on the human metabolism is deepened, more specialized product mixtures are being offered to improve athletic performance and for body-building.